Vaginal atrophy, or vaginal ageing, affects around 50 percent of menopausal and post-menopausal women. The walls of the vagina become thinner and the natural elasticity and blood supply is reduced. The protective mucosa of the vagina can lose hydration and thickness causing a loss of lubrication. The changes in the natural pH balance of the internal environment have detrimental effects on the function and health of the vagina.
The symptoms of vaginal atrophy may or may not occur simultaneously and may be felt as:
The symptoms of vaginal atrophy can have both a physical and emotional impact on the patient, including affecting their intimate relationships.
Around half of menopausal and post-menopausal women are affected by vaginal atrophy will experience some or all of the symptoms listed above.
In addition, younger women who have used the Pill for prolonged periods, breast-feeding mothers and women who experienced traumatic delivery and severe perineal repair and scarring may also experience these symptoms.
Around 60 per cent of breast cancer sufferers can also be affected by vaginal atrophy and unfortunately Hormone Replacement Therapy is not suitable for almost all of these patients meaning that there is no effective treatment for their symptoms.
Existing treatments involve making lifestyle changes to improve vulval care and using therapeutic creams such as a non-scented barrier cream or topical Hormone Replacement Therapy (HRT - vaginal oestrogen cream) if not contraindicated.
The effectiveness of these current treatments is highly dependent on the willingness of the patient to adhere to treatment protocols. In addition, the effects of existing treatments are short-term in nature and the benefits are no longer felt if the patient discontinues use.
In comparison, the Mona Lisa Touch procedure addresses a number of the issues causing vaginal atrophy, which means the effects of treatment are long lasting and will be felt independent of any actions performed by the patient.
The Mona Lisa Touch treatment is of particular benefit for patients with a past history, or strong family history of breast cancer who may have previously be advised against using HRT and until now have had no effective treatment for their symptoms of vaginal atrophy.
USA-based visitors please be aware that some of the brochures / information / intended uses / configurations / accessories mentioned here are not available in the USA and its territories and possessions.